Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection

Dig Dis Sci. 2014 Feb;59(2):273-81. doi: 10.1007/s10620-013-2773-z. Epub 2013 Aug 10.

Abstract

Background: Available data suggest problems in the process of care provided to patients with chronic hepatitis C (HCV). However, the solutions to these problems are less obvious. Healthcare facility factors are potentially modifiable and may enhance process quality in HCV treatment.

Methods: We evaluated the relationship between the process of HCV care and facility factors including number of weekly half-day HCV clinics per 1,000 HCV patients, HCV-specific quality-improvement initiatives, and administrative service of the HCV clinic (gastroenterology, infectious disease, primary care) for a cohort of 34,258 patients who sought care in 126 Veterans Affairs facilities during 2003-2006. We measured HCV care on the basis of 23 HCV-specific process measures capturing pretreatment (seven measures), preventive and/or comorbid (seven measures), and treatment and treatment monitoring care (nine measures).

Results: Patients seen at a facility with >8 half-day clinics were 52 % more likely to receive overall indicated care (OR 1.52, 95 % CI 1.13-2.05). Patients seen at a facility with >3 HCV quality improvement initiatives were more likely to receive better preventive and/or comorbid care (OR 1.32, 95 % CI 1.00-1.74). Compared with patients in facilities with no dedicated HCV clinic, patients at facilities with gastroenterology-based clinics received better pretreatment care (OR 1.36, 95 % CI 1.01-1.85) and more antiviral treatment (OR 1.45, 95 % CI 1.06-1.97) whereas those at facilities with infectious disease-based or primary care-based clinics received better preventive and/or comorbid care (OR 1.59, 95 % CI 1.06-2.39 and 1.84, 95 % CI 1.21-2.79 respectively).

Conclusion: Several facility factors affected the process of HCV care. These factors may serve as targets for quality-improvement efforts.

Publication types

  • Comparative Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ambulatory Care Facilities* / standards
  • Antiviral Agents / therapeutic use*
  • Appointments and Schedules
  • Comorbidity
  • Delivery of Health Care* / standards
  • Female
  • Gastroenterology* / standards
  • Hepatitis C, Chronic / diagnosis
  • Hepatitis C, Chronic / epidemiology
  • Hepatitis C, Chronic / therapy*
  • Humans
  • Infectious Disease Medicine* / standards
  • Linear Models
  • Logistic Models
  • Male
  • Middle Aged
  • Odds Ratio
  • Outcome and Process Assessment, Health Care* / standards
  • Preventive Health Services
  • Primary Health Care*
  • Quality Improvement
  • Quality of Health Care* / standards
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • United States / epidemiology
  • United States Department of Veterans Affairs

Substances

  • Antiviral Agents